View Clinical Trial (Medical Research Study)
G-CSF and Embryo Implantation and Pregnancy Following IVF
| City: |
|
New York |
| State: |
|
New York |
| Zip Code: |
|
10021 |
| Conditions: |
|
Infertility, Female |
| Purpose: |
|
This a trial designed to test whether granulocyte colony stimulating factor (G-CSF,
Neupogen) can increase the rate of embryo implantation following IVF and embryo transfer.
Preliminary data at CHR and elsewhere suggest that intrauterine infusion of G-CSF can
improve endometrial development and can increase implantation rates of embryos.
|
| Study Summary: |
|
Objective: To investigate the effect of treatment with CSF on pregnancy rates in routine in
vitro fertilization (IVF).
Design: Double blinded crossover randomized controlled clinical trial
Setting: Academically affiliated private infertility centers
Subjects: Normal female IVF patients 18-38 years old, and above age 38 years, who are
willing to be randomized to treatment.
Interventions: Subjects receive transvaginally, utilizing an insemination catheter, a slow
uterine lavage with G-CSF (Neupogen), 300ug (in 1 ml); controls receive saline. Patients
who do not conceive will, after one month washout time, continue treatment in the opposite
study arm.
Main Outcome Measures: Implantation and pregnancy rates.
Second Outcome Measures: Live birth rates and miscarriage rates.
Statistical and Power considerations: Analysis will be by regression with IR as dependent
and treatment as independent. Results will be adjusted by age and indices of ovarian
reserve, such as AMH. Presuming an implantation rate of 10% and anticipating a 10%
increase to 20% with treatment, 120 women, producing about 200 embryos in each study arm,
will have to be recruited for 80% power and alpha of 0.05.
|
| Criteria: |
|
Inclusion Criteria:
- Women already enrolled in an IVF cycle at one of the participating institutions
Exclusion Criteria:
- Sickle Cell disease
- Renal insufficiency
- Upper respiratory infection or Pneumonia
- Chronic Neutropenia
- Known Past or present malignancy
|
| NCT ID: |
|
NCT01202656 |
| Primary Contact: |
|
Principal Investigator
David H Barad, MD, MS
Center for Human Reproduction
Jolanta Tapper
Phone: 212 994-4400
Email: Jtapper@theCHR.com
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New York, New York 10021
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|